Genentech, Inc.
Genentech, Inc. (United States) holds 1 active US FDA Type II Drug Master File and 6 inactive and is linked to 7 FDA-registered manufacturing sites. 34 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Genentech, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/genentech-inc
Overview
Genentech, Inc., a biotechnology corporation, is a subsidiary of Roche Holding AG. The company specializes in developing and manufacturing products to treat patients with serious or life-threatening medical conditions, particularly in the areas of oncology, immunology, and neuroscience.
Therapeutic areas
API / Drug Master Files
Genentech, Inc. holds 1 active (7 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MSBA30K PEG REAGENT FOR MIRCERA (RO0503819)Active2006-06-29
- CED88004SInactive2017-08-11
- CED88004AInactive2017-08-11
- DORNASE ALFA INHALATION SOLUTION (GENENTECH)Inactive1999-11-09
- THROMBOPOIETIN (HUMAN, RECOMBINANT, CHO CELLS, GENENTECH)Inactive1995-08-21
- TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN GInactive1993-11-11
- MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SOUTH SAN FRANCISCO.Inactive1980-11-21
Registered manufacturing sites (7)
Physical sites registered with the US FDA and resolved to Genentech, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- F. Hoffmann-La Roche AGKaiseraugst, Switzerland · API manufactureSite GMP match
- F. Hoffmann-La Roche AGBasel, Switzerland · API manufactureSite GMP match
- Genentech, Inc.South San Francisco, United States · API manufacture
- Genentech, Inc.Oceanside, United States · API manufacture
- Roche Diagnostics GmbHPenzberg, Germany · API manufactureSite GMP match
- Roche Diagnostics GmbHMannheim, Germany · API manufactureSite GMP match
- Roche Singapore Technical Operations Pte. Ltd.Singapore, Singapore · API manufactureSite GMP match
FDA compliance signals
34 FDA enforcement records linked to this company.
- recall — Class II2024-06-05
Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.
- 4832024-05-02
Failure to comply with REMS Implementation System
- 4832024-04-19
Written procedures not established/followed
- 4832024-04-19
Written record of investigation incomplete
- 4832024-04-19
Cleaning / Sanitizing / Maintenance
- 4832024-04-19
Testing Calculations
- 4832024-04-19
Establishment of calibration procedures
- 4832024-04-19
Master production and control records, procedure
- 4832024-04-19
Scientifically sound laboratory controls
- recall — Class III2022-11-09
Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.
- recall — Class II2021-07-14
Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content were detected at the 12 month testing time point.
- recall — Class III2021-05-05
Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.
- 4832018-07-05
Following/documenting laboratory controls
- 4832018-07-05
Cleaning SOPs/schedules
- 4832018-07-05
Establishment of calibration procedures
- 4832018-07-05
Investigations of discrepancies, failures
- 4832018-07-05
Procedures for sterile drug products
- recall — Class III2018-02-21
Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.
- recall — Class I2017-09-27
Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.
- recall — Class II2017-04-12
Superpotent Drug: An oversized tablet was found in a bottle.
- 4832016-07-08
Authority lacking to review records, investigate errors
- 4832016-07-08
Records reviewed annually
- 4832016-04-15
Cleaning / Sanitizing / Maintenance
- 4832016-04-15
Procedures for sterile drug products
- recall — Class I2013-01-30
Presence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials that were packed with Trastuzumab Kits for investigational use has the potential to contain glass particulates.
- recall — Class III2012-12-26
Short Fill: some bottles contained less than 120-count per labeled claim.
- recall — Class II2012-12-12
Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).
- recall — Class II2012-12-12
Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).
- 4832011-06-23
Aseptic Processing Area
- 4832011-06-23
Defined areas of adequate size for operations
- 4832011-06-23
Following/documenting laboratory controls
- 4832011-06-23
No written record of investigation
- 4832011-06-23
Validation lacking for sterile drug products
- 4832011-06-23
Written record of investigation incomplete
Is this Genentech, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.